Cargando…

Evaluation of BDNF as a Biomarker for Impulsivity in a Psychiatric Population

Impulsivity is an important risk factor for suicide and therefore, identifying biomarkers associated with impulsivity could be important in evaluating psychiatric patients. Currently, assessment of impulsivity is based solely on clinical evaluation. In this study, brain-derived neurotrophic factor (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasyk, Stanislav, Sanger, Nitika, Kapczinski, Flavio, Samaan, Zainab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345173/ https://www.ncbi.nlm.nih.gov/pubmed/32575733 http://dx.doi.org/10.3390/diagnostics10060419

Ejemplares similares

Exploring the Impact of Modifiable Factors on Serum BDNF in Psychiatric Patients and Community Controls
por: Chan, Galen, et al.
Publicado: (2021)

Association between vaping and health outcomes in patients with opioid use disorder: a systematic review protocol
por: Sanger, Nitika, et al.
Publicado: (2021)

Identifying patient-important outcomes for treatment of bipolar disorder: a systematic review protocol
por: D'Elia, Alessia, et al.
Publicado: (2021)

Corrigendum to ‘A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis’ [EClinicalMedicine 24 (2020) 100442]
por: Sanger, Nitika, et al.
Publicado: (2021)

Psychosis and Comorbid Opioid Use Disorder: Characteristics and Outcomes in Opioid Substitution Therapy
por: Lamont, Rachel, et al.
Publicado: (2020)

The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences
por: Naji, Leen, et al.
Publicado: (2018)

Genetic basis of cannabis use: a systematic review
por: Hillmer, Alannah, et al.
Publicado: (2021)

Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol
por: Sanger, Nitika, et al.
Publicado: (2018)

The Role of BDNF as a Mediator of Neuroplasticity in Bipolar Disorder
por: Grande, Iria, et al.
Publicado: (2010)

Genetic determinants of cannabis use: a systematic review protocol
por: Hillmer, Alannah, et al.
Publicado: (2020)

Impulsivity and Metacognition in a Psychiatric Population
por: Turiaco, Fabrizio, et al.
Publicado: (2022)

Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review
por: van Reekum, Emma A., et al.
Publicado: (2021)

Outcomes reported in randomised controlled trials of major depressive disorder in older adults: protocol for a methodological review
por: Rodrigues, Myanca, et al.
Publicado: (2021)

Investigating and addressing the immediate and long-term consequences of the COVID-19 pandemic on patients with substance use disorders: a scoping review and evidence map protocol
por: Naji, Leen, et al.
Publicado: (2021)

Impact of COVID-19 and other pandemics and epidemics on people with pre-existing mental disorders: a systematic review protocol and suggestions for clinical care
por: Sergeant, Anjali, et al.
Publicado: (2020)

Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences
por: Chawar, Caroul, et al.
Publicado: (2021)

The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder
por: Naji, Leen, et al.
Publicado: (2021)

A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder
por: Chawar, Caroul, et al.
Publicado: (2021)

GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol
por: Chawar, Caroul, et al.
Publicado: (2020)

A study on socio-demographic profile, impulsivity, psychiatric morbidity among suicide attempters
por: Syed.Zainab,, et al.
Publicado: (2022)

Association between BDNF levels and suicidal behaviour: a systematic review protocol
por: Eisen, Rebecca, et al.
Publicado: (2015)

Association between BDNF levels and suicidal behaviour: a systematic review and meta-analysis
por: Eisen, Rebecca B., et al.
Publicado: (2015)

The Inclusion of Patients’ Reported Outcomes to Inform Treatment Effectiveness Measures in Opioid Use Disorder. A Systematic Review
por: Sanger, Nitika, et al.
Publicado: (2022)

Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
por: van Reekum, Emma A., et al.
Publicado: (2020)

Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada
por: Rosic, Tea, et al.
Publicado: (2021)

Adult ADHD: Questioning Diagnosis and Treatment in a Patient with Multiple Psychiatric Comorbidities
por: Chu, Robert Karoly, et al.
Publicado: (2017)

Virtual psychiatric care fast-tracked: reflections inspired by the COVID-19 pandemic
por: Rosic, Tea, et al.
Publicado: (2020)

Sociodemographic characteristics of patients with children in a methadone maintenance program: a cross-sectional study
por: Luo, Candice, et al.
Publicado: (2019)

The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders
por: Cattaneo, A, et al.
Publicado: (2016)

Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder
por: Chai, Darren, et al.
Publicado: (2021)

Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?
por: Au, Vivian Y. O., et al.
Publicado: (2021)

Effects of childhood trauma on BDNF and TBARS during crack-cocaine withdrawal
por: Sordi, Anne O., et al.
Publicado: (2019)

Metabolic syndrome and psychiatric disorders: a population-based study
por: Moreira, Fernanda Pedrotti, et al.
Publicado: (2018)

The association between cannabis use and outcome in pharmacological treatment for opioid use disorder
por: Rosic, Tea, et al.
Publicado: (2021)

Genetics of cannabis use in opioid use disorder: A genome-wide association and polygenic risk score study
por: Hillmer, Alannah, et al.
Publicado: (2023)

Factors affecting participant recruitment and retention in borderline personality disorder research: a feasibility study
por: Woo, Julia, et al.
Publicado: (2021)

Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data
por: Naji, Leen, et al.
Publicado: (2022)

Serum BDNF levels in unaffected first-degree relatives of patients with bipolar disorder
por: Nery, Fabiano G., et al.
Publicado: (2016)

Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis
por: Sanger, Nitika, et al.
Publicado: (2020)

Are patients’ goals in treatment associated with expected treatment outcomes? Findings from a mixed-methods study on outpatient pharmacological treatment for opioid use disorder
por: Rosic, Tea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kgtq8dej2tiqt09c5lq4t8fvh0